The short answer
Ginkgo supplements deserve review while taking pirtobrutinib, especially if you have low platelets or other bleeding risks. A direct increase in bleeding from this exact combination has not been measured.
What this answer covers
Oral pirtobrutinib with ginkgo supplements. Dose and exact preparation matter; food exposures and other plant parts are distinct.
- Supplement or preparation
- Ginkgo biloba
- Medication ingredient
- pirtobrutinib
Check the prescribed treatment
This review concerns oral pirtobrutinib tablets used for selected blood cancers. Pirtobrutinib is a reversible BTK inhibitor, and interaction findings or dose adjustments from other BTK medicines should not be copied to it. Keep your prescribed dosing and blood-count monitoring plan.
Why the team needs the product details
Pirtobrutinib can cause serious bleeding or low platelet counts. The relevant ginkgo guidance concerns leaf preparations, not seeds or every product sold under the plant name. The exact product and the rest of your medicines should be reviewed together.
What the human evidence does not prove
A short trial of a defined ginkgo leaf extract with aspirin found no additional bleeding-time or platelet effect. Participants were healthy volunteers taking a different medicine; the result cannot establish safety during treatment-related low platelets.
Follow the monitoring and symptom plan
Report unusual bruising or persistent bleeding, and seek urgent help for major bleeding, black stools or vomiting blood. Keep the prescribed blood-count checks. Do not stop the cancer drug or rely on a gap between doses to prevent a possible effect on clotting.
Evidence and practical considerations
Side effects & toxicity
The drug bleeding warning and supplement-specific guidance support a conditional precaution, with human counterevidence retained.
- Exact scope
- Oral pirtobrutinib with ginkgo supplements. Dose and exact preparation matter; food exposures and other plant parts are distinct. with RxNorm 2629338 IN pirtobrutinib. Exact current oral product: JAYPIRCA oral pirtobrutinib tablets. Salt, formulation and regimen distinctions explicit.
- Medication form and route
- Oral
What remains uncertain
- No exact co-use bleeding-outcome trial. Conditional supplement-specific bridge; healthy or other-drug null results and formulation limits retained.
Factors that may matter: Exact oral formulation and supplement preparation; Drug exposure versus clinical outcomes; Dose and duration; Platelet count and neurological symptoms.
Read the supporting source summaries
Source 1: Current original prescribing information
dailymed.nlm.nih.gov · Source check Sep 11, 2026
Population: Patients prescribed the exact oral formulation.
Bleeding/cytopenia warnings; strong inhibitor AUC increase 49% and strong inducer reduction 71%; product-specific management.
How this applies: RxNorm 2629338 IN pirtobrutinib. Exact current oral product: JAYPIRCA oral pirtobrutinib tablets. Salt, formulation and regimen distinctions explicit.
Exact product source, not a direct study of every supplement. Population, active metabolites and formulation scope retained.
Source 2: Original official botanical monograph
ema.europa.eu · Source check Sep 11, 2026
Population: Users of defined leaf medicines.
Bleeding susceptibility and other clotting medicines warrant review.
How this applies: Conditional leaf-preparation precaution.
No exact target-drug trial or transferable incidence.
Source 3: Original clinical research
pubmed.ncbi.nlm.nih.gov · Source check Sep 11, 2026
Population: 50 healthy men.
No additional bleeding-time or platelet/coagulation effect.
How this applies: Exact preparation/population/endpoints only; applicability to pirtobrutinib independently assessed.
Abstract-only short healthy trial with another drug; cannot establish safety during cancer-treatment thrombocytopenia.
Source 4: Medication terminology
rxnav.nlm.nih.gov · Source check Sep 11, 2026
Population: Terminology.
pirtobrutinib is IN.
How this applies: Exact ingredient.
Not clinical evidence.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Research summary published | |
| Article prepared | |
| Sources checked and article drafted. |
Article revision: e927ade780f9b6a1
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.